• 27 Mar 20

Genedrive PLC looking to have its coronavirus test available in around eight weeks

Genedrive PLC looking to have its coronavirus test available in around eight weeks

Genedrive Plc | GDR | 1.4 0 0%

    • 113 views

 

Genedrive PLC's (LON:GDR) David Budd tells Proactive London's Andrew Scott a clinically validated high throughput format for its coronavirus test could be available in approximately eight weeks.

Its 96 SARS-COV-2 test can determine whether someone is infected with coronavirus.

As the test is freeze dried, it requires no refrigeration and is easier to transport

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via our Refer a Friend page. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Genedrive CEO on rapid genetic testing rollout - One2One Investor Forum

Companies: Genedrive Plc

Genedrive PLC - Capital Network: Overlooked Story Entering the Launch of their HepC Diagnostic Kit

Companies: Genedrive Plc

Genedrive target US and Europe with Beckman Coulter for Covid-19 testing technology

Companies: Genedrive Plc

Genedrive's David Budd details launch of its unique coronavirus test kits and plans for first sales

Companies: Genedrive Plc

Investor Update: Genedrive reports 'high clinical accuracy' for its AIHL assay kit

Companies: Genedrive Plc

Genedrive's David Budd hails CE mark for its infant hearing loss test

Companies: Genedrive Plc

© Research Tree 2025

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top